PHGE

Conviction 4HealthcareScan · Mon, Aug 10, 2026

PHGE$0.1610-6.29%

ResistanceSupportVol 14

Vol MA14 2.26M

May 11May 28Jun 16Jul 6Jul 23Aug 10

BiomX Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.biomx.com ↗

Price0.1610

Change-6.29%

Gap-1.16%

Rel volume0.01×

Avg volume1.83M

Avg $ vol342.49K

SMA 200.1903

SMA 500.3999

SMA 2002.25

Price vs 50-59.74%

Price vs 200-92.84%

MA stackbearish

50/200 cross—

Supertrenddown · 0.2331

RSI (14)27

MACD hist0.02

MACD cross—

Stoch %K / %D46 / 50

ADX (14)38

+DI / −DI12 / 36

RSI divergenceBullish

MACD divergenceBullish

ATR %+21.88%

ADR %9.70%

52w high7.50

52w low0.1598

From 52w high-97.85%

Above 52w low+0.75%

New 52w highNo

SqueezeOn · 7d

Bollinger width31.06%

%B0.00

Donchian pos38.42%

Donchian high0.2280

Donchian low0.1192

AVWAP (52w high)0.7252

vs AVWAP high-77.80%

AVWAP (52w low)0.1554

vs AVWAP low+3.60%

OBV trendDown

Chaikin MF (20)0.06

Today vs 20d0.01×

Avg vol (14d)2.26M

Avg vol (20d)1.83M

Avg $ vol (20d)342.49K

Market cap1.63M

RS 3m (vs SPY)-77.95%

RS 6m (vs SPY)-110.35%

RS line new highNo

Trend template1/8

Technical rank1.0

1 week-13.81%

1 month-30.60%

3 months-74.32%

6 months-95.90%

1 year-72.89%

YTD-92.48%

P/E-0.05

P/B-1.85

P/S—

P/FCF-0.06

EPS22.19

Div yield—

ROE—

ROA—

Debt/Eq-12.70

Current1.24

EV/EBITDA-0.27

Gross margin—

Net margin—

Rev growth—

EPS growth-104.20%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value11.65M

Revenue—

Net income-19.14M

Gross profit—

Free cash flow-26.39M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out11.16M

Employees20

ListedWed, Mar 13, 2019

Free float3.7M

Float %56.5%

Short interest190.32K

Days to cover0.0d

Short volume28.5%

Squeeze score10 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank1.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.2100

Support0.1444

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PHGE

All disclosures →

No recent disclosed trades by Congress in PHGE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHGE

No recent insider (Form 4) filings in PHGE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in PHGE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.